Evidence map›Paper›PMID 29758263›Full record

ArticleJournal of molecular biology2018

PAGE4 and Conformational Switching: Insights from Molecular Dynamics Simulations and Implications for Prostate Cancer.

Xingcheng Lin, Susmita Roy, Mohit Kumar Jolly, Federico Bocci, Nicholas P Schafer, Min-Yeh Tsai, Yihong Chen, Yanan He, Alexander Grishaev, Keith Weninger and 5 more

Abstract read
In one paragraph

Article in Journal of molecular biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Article
  3. Theoretical and computational tools to model multistable gene regulatory networks.Reports on progress in physics. Physical Society (Great Britain) · 2023
    Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Journal of biosciences · 2022
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 2 countries.

Xingcheng LinCenter for Theoretical Biological Physics, Rice University, Houston, TX 77005, United States; Department of Physics and Astronomy, Rice University, Houston, TX 77005, United States.
Susmita RoyCenter for Theoretical Biological Physics, Rice University, Houston, TX 77005, United States.
Mohit Kumar JollyCenter for Theoretical Biological Physics, Rice University, Houston, TX 77005, United States.
Federico BocciCenter for Theoretical Biological Physics, Rice University, Houston, TX 77005, United States; Department of Chemistry, Rice University, Houston, TX 77005, United States.
Nicholas P SchaferCenter for Theoretical Biological Physics, Rice University, Houston, TX 77005, United States; Department of Chemistry, Rice University, Houston, TX 77005, United States.
Min-Yeh TsaiCenter for Theoretical Biological Physics, Rice University, Houston, TX 77005, United States; Department of Chemistry, Rice University, Houston, TX 77005, United States.
Yihong ChenInstitute for Bioscience and Biotechnology Research, University of Maryland, Rockville, MD 20850, United States.
Yanan HeInstitute for Bioscience and Biotechnology Research, University of Maryland, Rockville, MD 20850, United States.
Alexander GrishaevInstitute for Bioscience and Biotechnology Research, University of Maryland, Rockville, MD 20850, United States; National Institute of Standards and Technology, Gaithersburg, MD 20899, United States.
Keith WeningerDepartment of Physics, North Carolina State University, Raleigh, NC 27695, United States.
John OrbanInstitute for Bioscience and Biotechnology Research, University of Maryland, Rockville, MD 20850, United States; Department of Chemistry and Biochemistry, University of Maryland, College Park, MD 20742, United States.
Prakash KulkarniInstitute for Bioscience and Biotechnology Research, University of Maryland, Rockville, MD 20850, United States; Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, CA 91010, United States.
Govindan RangarajanDepartment of Mathematics, Indian Institute of Science, Bangalore 560012, India; Center for Neuroscience, Indian Institute of Science, Bangalore 560012, India.
Herbert LevineCenter for Theoretical Biological Physics, Rice University, Houston, TX 77005, United States; Department of Physics and Astronomy, Rice University, Houston, TX 77005, United States.
José N OnuchicCenter for Theoretical Biological Physics, Rice University, Houston, TX 77005, United States; Department of Physics and Astronomy, Rice University, Houston, TX 77005, United States; Department of Chemistry, Rice University, Houston, TX 77005, United States; Department of BioSciences, Rice University, Houston, TX 77005, United States. Electronic address: jonuchic@rice.edu.
Center for Theoretical Biological Physics · USRice University · USAdvanced Bioscience Laboratories (United States) · USIndian Institute of Science Bangalore · INInstitute for Bioscience and Biotechnology ResearchNational Institute of Standards and Technology · USNorth Carolina State University · US

Funding

Structure and stability of 3_alpha vs alpha_beta foldsR01GM062154 · NIGMS · UNIV OF MARYLAND, COLLEGE PARK · PI BRYAN, PHILIP N, ORBAN, JOHN · 2002 to 2016
$3.2M
PAGE4 as a Novel Target for Prostate Cancer PreventionR21CA181730 · NCI · UNIV OF MARYLAND, COLLEGE PARK · PI KULKARNI, PRAKASH, ORBAN, JOHN · 2014 to 2015
$364k
NCI NIH HHS R21 CA181730NIGMS NIH HHS R01 GM062154
6 · The paper itself

Abstract

Prostate-associated gene 4 (PAGE4) is an intrinsically disordered protein implicated in prostate cancer. Thestress-response kinase homeodomain-interacting protein kinase 1 (HIPK1) phosphorylates two residues in PAGE4, serine 9 and threonine 51. Phosphorylation of these two residues facilitates the interaction of PAGE4 with activator protein-1 (AP-1) transcription factor complex to potentiate AP-1's activity. In contrast, hyperphosphorylation of PAGE4 by CDC-like kinase 2 (CLK2) attenuates this interaction with AP-1. Small-angleX-ray scattering and single-molecule fluorescence resonance energy transfer measurements have shown that PAGE4 expands upon hyperphosphorylation and that this expansion is localized to its N-terminal half. To understand the interactions underlying this structural transition, we performed molecular dynamics simulations using Atomistic AWSEM, a multi-scale molecular model that combines atomistic and coarse-grained simulation approaches. Our simulations show that electrostatic interactions drive transient formation of an N-terminal loop, the destabilization of which accounts for the dramatic change in size upon hyperphosphorylation. Phosphorylation also changes the preference of secondary structure formation of the PAGE4 ensemble, which leads to a transition between states that display different degrees of disorder. Finally, we construct a mechanism-based mathematical model that allows us to capture the interactions ofdifferent phosphoforms of PAGE4 with AP-1 and its downstream target, the androgen receptor (AR)-a key therapeutic target in prostate cancer. Our model predicts intracellular oscillatory dynamics of HIPK1-PAGE4, CLK2-PAGE4, and AR activity, indicating phenotypic heterogeneity in an isogenic cell population. Thus, conformational switching of PAGE4 may potentially affect the efficiency of therapeutically targeting AR activity.

Indexed as

Antigens, NeoplasmFluorescence Resonance Energy TransferHumansMaleModels, MolecularModels, TheoreticalMolecular Dynamics SimulationPhosphorylationProstatic NeoplasmsProtein ConformationProtein Serine-Threonine KinasesProtein-Tyrosine KinasesReceptors, AndrogenScattering, Small AngleSignal TransductionSingle Molecule ImagingAntigens, NeoplasmAR protein, humanClk dual-specificity kinasesHIPK1 protein, humanPAGE4 protein, humanProtein Serine-Threonine KinasesProtein-Tyrosine KinasesReceptors, AndrogenTranscription Factor AP-1AWSEMintrinsically disordered proteinnon-genetic heterogeneityorder–disorder transitionPAGE4

Identifiers

PMID29758263
PMCPMC6045464
OpenAlexW2949746824

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.